查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1697960

全球分子传染病检测市场：市场规模、占有率、趋势、产业分析（按产品/服务、类型、检测类型、疾病、技术、最终用户和地区）、未来预测（2025-2034）

Molecular Infectious Disease Testing Market Size, Share, Trends, Industry Analysis Report: By Product & Service, Type, Test Type, Disease, Technology, End User, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，分子传染病检测市场预计到 2034 年将达到 347.3 亿美元。该报告提供了有关当前市场动态的详细见解，并对未来市场成长进行了分析。

分子传染病检测是指检测和分析病原体遗传物质的先进诊断技术，能够准确、早期地识别疾病。分子传染病检测市场的关键趋势是扩大采用多重分子诊断方法，这种方法可以在一次测试中同时检测多种病原体。这项进步将提高诊断效率、缩短週转时间并改善临床决策。对快速、广谱诊断解决方案的需求不断增长，尤其是在急性护理环境中，这推动了多重检测进一步融入常规分子检测，从而加强了其在传染病管理中的作用。

影响分子传染病检测市场需求的另一个主要趋势是自动化和人工智慧 (AI) 在诊断工作流程中的日益融合。自动化分子检测平台提高了实验室效率，最大限度地减少了人为错误，并提供了更大的可扩展性以满足日益增长的检测需求。人工智慧驱动的数据分析进一步完善了结果的解释，促进了更准确的诊断和预测分析。自动化和人工智慧的结合简化了分子诊断，使得整个医疗保健环境中的检测更加容易和可靠，从而加速了分子传染病检测市场的成长。

分子传染病检测市场：概述

根据疾病概况，由于性传染​​病 (STI) 盛行率不断上升以及对精确和早期诊断解决方案的需求不断增加，预计性传染病 (STD) 领域将在 2024 年占据分子传染病检测市场占有率的首位。

基于产品/服务，由于分子诊断测试在各种医疗保健环境中的使用越来越多，预计试剂和试剂盒部分将在预测期内见证最快的市场成长。

由于北美拥有发达的医疗保健基础设施、先进诊断技术的高度采用以及支持分子检测的强大监管框架，预计到 2024 年，北美将成为分子传染病检测市场收入占有率的领先者。

由于医疗保健投资的增加、对早期疾病检测的认识的提高以及传染病患者病率的上升，预计亚太地区分子传染病检测市场将在预测期内实现最高增长率。

全球市场的主要参与者包括Abbott, Danaher, bioMerieux, Hoffmann-La Roche, Bio-Rad Laboratories, Agilent Technologies, Becton Dickinson, Hologic (Gen-Probe), Illumina, Grifols, Qiagen, Siemens Healthineers, Sysmex, Bruker, Thermo Fisher Scientific。

目录

第一章简介

第 2 章执行摘要

第三章 分析方法

第四章 全球分子传染病检测市场洞察

  • 市场概况
  • 分子传染病检测的市场动态
    • 推动因素和机遇
      • 传染病增加
      • 分子诊断技术的快速进步
    • 阻碍因素和课题
      • 退款政策不一致
  • PESTLE 分析
  • 分子传染病检测市场：分销通路趋势
  • 价值链分析

5.全球分子传染病检测市场（依产品及服务）

  • 主要发现
  • 简介
  • 试剂和试剂盒
  • 设备
  • 服务软体

第六章全球分子传染病检测市场（按类型）

  • 主要发现
  • 简介
  • 多重测试
  • 单重测试

7.全球分子传染病检测市场（依检测类型）

  • 主要发现
  • 简介
  • 实验室测试
  • 即时检定

8.全球分子传染病检测市场（依疾病类型）

  • 主要发现
  • 简介
  • 呼吸道感染
  • 胃肠道感染
  • 性传染病
  • 医院内感染
  • 阴道炎
  • 脑膜炎
  • 传播疾病
  • 其他传染病

第九章：全球分子传染病检测市场（依技术）

  • 主要发现
  • 简介
  • 聚合酶炼式反应 (PCR)
  • 等温核酸扩增技术（INACT）
  • DNA定序/次世代定序
  • 原位杂交
  • DNA微阵列
  • 其他

第 10 章。全球分子传染病检测市场（依最终用户划分）

  • 主要发现
  • 简介
  • 诊断实验室
  • 医院和诊所
  • 其他

第 11 章：全球分子传染病检测市场（按地区）

  • 主要发现
  • 简介
    • 分子传染病检测市场（按地区）分析（2020-2034）
  • 北美
    • 北美地区（按产品和服务划分） (2020-2034)
    • 北美，按类型划分（2020-2034 年）
    • 北美，依测验类型划分（2020-2034 年）
    • 北美疾病分类（2020-2034 年）
    • 北美地区技术分类（2020-2034 年）
    • 北美地区最终用户分布（2020-2034 年）
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依产品与服务（2020-2034 年）
    • 欧洲各类型（2020-2034 年）
    • 欧洲，依测验类型划分（2020-2034 年）
    • 欧洲：依疾病分类（2020-2034 年）
    • 欧洲技术分布（2020-2034）
    • 欧洲最终用户分布（2020-2034 年）
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 亚太地区：依产品与服务，2020-2034 年
    • 亚太地区按类型划分（2020-2034 年）
    • 亚太地区考试类型（2020-2034）
    • 亚太地区：依疾病分类（2020-2034 年）
    • 亚太地区技术分布（2020-2034）
    • 亚太地区最终用户分布（2020-2034）
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲
    • 中东和非洲：按产品和服务划分（2020-2034 年）
    • 中东与非洲：依类型（2020-2034 年）
    • 中东和非洲：按测试类型（2020-2034 年）
    • 中东与非洲：依疾病分类（2020-2034 年）
    • 中东和非洲：依技术分类（2020-2034 年）
    • 中东和非洲：按最终用户划分（2020-2034 年）
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
    • 拉丁美洲依产品与服务划分（2020-2034 年）
    • 拉丁美洲各类型（2020-2034）
    • 拉丁美洲各测试类型（2020-2034）
    • 拉丁美洲，依疾病分类（2020-2034 年）
    • 拉丁美洲的技术状况（2020-2034 年）
    • 拉丁美洲最终用户分布（2020-2034 年）
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第 12 章 竞争格局

  • 业务扩张与收购分析
    • 业务扩展
    • 收购
  • 伙伴关係/协作/协议/揭露

第 13 章公司简介

  • Abbott
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Grifols S.A.
  • Hologic, Inc. (Gen-Probe)
  • Illumina, Inc.
  • Qiagen
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific
Product Code: PM5437

The molecular infectious disease testing market size is expected to reach USD 34.73 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Infectious Disease Testing Market Share, Size, Trends, Industry Analysis Report: By Product & Service, Type (Multiplex Testing and Singleplex Testing), Test Type, Disease, Technology, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Molecular infectious disease testing refers to advanced diagnostic techniques that detect and analyze the genetic material of pathogens to enable precise and early disease identification. A major molecular infectious disease testing market trend is the increasing adoption of multiplex molecular diagnostics, which allow the simultaneous detection of multiple pathogens in a single test. This advancement improves diagnostic efficiency, reduces turnaround time, and improves clinical decision-making. The growing demand for rapid and wide diagnostic solutions, particularly in acute care settings, is further driving the integration of multiplex assays into routine molecular testing, strengthening their role in infectious disease management.

Another major trend shaping the molecular infectious disease testing market demand is the rising integration of automation and artificial intelligence (AI) in diagnostic workflows. Automated molecular testing platforms are improving laboratory efficiency, minimizing human errors, and improving scalability to meet the increasing testing demand. AI-driven data analysis is further refining result interpretation, facilitating more accurate diagnoses and predictive analytics. The combination of automation and AI is streamlining molecular diagnostics, making testing more accessible and reliable across various healthcare settings, thereby accelerating molecular infectious disease testing market growth.

Molecular Infectious Disease Testing Market Report Highlights

In terms of disease, the sexually transmitted disease (STD) segment led the molecular infectious disease testing market share in 2024, driven by the rising incidence of STIs and the growing need for precise and early diagnostic solutions.

Based on product & service, the reagents & kits segment is anticipated to experience the most rapid growth in the market during the forecast period, fueled by the increasing utilization of molecular diagnostic tests across various healthcare settings.

North America emerged as the leading region in the global molecular infectious disease testing market revenue share in 2024, attributed to its well-developed healthcare infrastructure, high adoption of advanced diagnostic technologies, and a robust regulatory framework supporting molecular testing.

The molecular infectious disease testing market in Asia Pacific is expected to witness the highest growth rate during the forecast period, driven by expanding healthcare investments, greater awareness of early disease detection, and a rising prevalence of infectious diseases.

A few global key market players include Abbott; Danaher Corporation; bioMerieux SA; F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Becton, Dickinson and Company; Hologic, Inc. (Gen-Probe); Illumina, Inc., Grifols S.A.; Qiagen; Siemens Healthineers AG; Sysmex Corporation; Bruker Corporation; and Thermo Fisher Scientific.

Polaris Market Research has segmented the molecular infectious disease testing market report on the basis of product & service, type, test type, disease, technology, end user, and region:

By Product & Service Outlook (Revenue, USD Billion, 2020-2034)

  • Reagents & Kits
  • Instruments
  • Services & Software

By Type Outlook (Revenue, USD Billion, 2020-2034)

  • Multiplex Testing
  • Singleplex Testing

By Test Type Outlook (Revenue, USD Billion, 2020-2034)

  • Laboratory Tests
  • Point-of-Care Tests

By Disease Outlook (Revenue, USD Billion, 2020-2034)

  • Respiratory Infectious Diseases
  • Gastrointestinal Infectious Diseases
  • Sexually Transmitted Diseases
  • Hospital-Acquired Infections
  • Vaginitis
  • Meningitis
  • Vector-Borne Diseases
  • Other Infectious Diseases

By Technology Outlook (Revenue, USD Billion, 2020-2034)

  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • DNA-Sequencing & Next-Generation Sequencing
  • In-Situ Hybridization
  • DNA Microarrays
  • Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Molecular Infectious Disease Testing Market Insights

  • 4.1. Molecular Infectious Disease Testing Market - Distribution Channel Snapshot
  • 4.2. Molecular Infectious Disease Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Cases of Infectious Diseases
      • 4.2.1.2. Rapid Technological Advancements in Molecular Diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Inconsistent Reimbursement Policies
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Molecular Infectious Disease Testing Market Distribution Channel Trends
  • 4.6. Value Chain Analysis

5. Global Molecular Infectious Disease Testing Market, by Product & Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • 5.3. Reagents & Kits
    • 5.3.1. Global Molecular Infectious Disease Testing Market, by Pan-based Molecular Infectious Disease Testing, by Region, 2020-2034 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Molecular Infectious Disease Testing Market, by Instruments, by Region, 2020-2034 (USD Billion)
  • 5.5. Services & Software
    • 5.5.1. Global Molecular Infectious Disease Testing Market, by Services & Software, by Region, 2020-2034 (USD Billion)

6. Global Molecular Infectious Disease Testing Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • 6.3. Multiplex Testing
    • 6.3.1. Global Molecular Infectious Disease Testing Market, by Multiplex Testing, by Region, 2020-2034 (USD Billion)
  • 6.4. Singleplex Testing
    • 6.4.1. Global Molecular Infectious Disease Testing Market, by Singleplex Testing, by Region, 2020-2034 (USD Billion)

7. Global Molecular Infectious Disease Testing Market, by Test Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • 7.3. Laboratory Tests
    • 7.3.1. Global Molecular Infectious Disease Testing Market, by Laboratory Tests, by Region, 2020-2034 (USD Billion)
  • 7.4. Point-of-Care Tests
    • 7.4.1. Global Molecular Infectious Disease Testing Market, by Point-of-Care Tests, by Region, 2020-2034 (USD Billion)

8. Global Molecular Infectious Disease Testing Market, by Disease

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • 8.3. Respiratory Infectious Diseases
    • 8.3.1. Global Molecular Infectious Disease Testing Market, by Respiratory Infectious Diseases, by Region, 2020-2034 (USD Billion)
  • 8.4. Gastrointestinal Infectious Diseases
    • 8.4.1. Global Molecular Infectious Disease Testing Market, by Gastrointestinal Infectious Diseases, by Region, 2020-2034 (USD Billion)
  • 8.5. Sexually Transmitted Diseases
    • 8.5.1. Global Molecular Infectious Disease Testing Market, by Sexually Transmitted Diseases, by Region, 2020-2034 (USD Billion)
  • 8.6. Hospital-Acquired Infections
    • 8.6.1. Global Molecular Infectious Disease Testing Market, by Hospital-Acquired Infections, by Region, 2020-2034 (USD Billion)
  • 8.7. Vaginitis
    • 8.7.1. Global Molecular Infectious Disease Testing Market, by Vaginitis Diseases, by Region, 2020-2034 (USD Billion)
  • 8.8. Meningitis
    • 8.8.1. Global Molecular Infectious Disease Testing Market, by Meningitis, by Region, 2020-2034 (USD Billion)
  • 8.9. Vector-Borne Diseases
    • 8.9.1. Global Molecular Infectious Disease Testing Market, by Vector-Borne Diseases, by Region, 2020-2034 (USD Billion)
  • 8.10. Other Infectious Diseases
    • 8.10.1. Global Molecular Infectious Disease Testing Market, by Other Infectious Diseases, by Region, 2020-2034 (USD Billion)

9. Global Molecular Infectious Disease Testing Market, by Technology

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • 9.3. Polymerase Chain Reaction
    • 9.3.1. Global Molecular Infectious Disease Testing Market, by Polymerase Chain Reaction, by Region, 2020-2034 (USD Billion)
  • 9.4. Isothermal Nucleic Acid Amplification Technology
    • 9.4.1. Global Molecular Infectious Disease Testing Market, by Isothermal Nucleic Acid Amplification Technology, by Region, 2020-2034 (USD Billion)
  • 9.5. DNA-Sequencing & Next-Generation Sequencing
    • 9.5.1. Global Molecular Infectious Disease Testing Market, by DNA-Sequencing & Next-Generation Sequencing, by Region, 2020-2034 (USD Billion)
  • 9.6. In-Situ Hybridization
    • 9.6.1. Global Molecular Infectious Disease Testing Market, by In-Situ Hybridization, by Region, 2020-2034 (USD Billion)
  • 9.7. DNA Microarrays
    • 9.7.1. Global Molecular Infectious Disease Testing Market, by DNA Microarrays, by Region, 2020-2034 (USD Billion)
  • 9.8. Others
    • 9.8.1. Global Molecular Infectious Disease Testing Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Molecular Infectious Disease Testing Market, by End User

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 10.3. Diagnostic Laboratories
    • 10.3.1. Global Molecular Infectious Disease Testing Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
  • 10.4. Hospitals & Clinics
    • 10.4.1. Global Molecular Infectious Disease Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
  • 10.5. Others
    • 10.5.1. Global Molecular Infectious Disease Testing Market, by Others, by Region, 2020-2034 (USD Billion)

11. Global Molecular Infectious Disease Testing Market, by Geography

  • 11.1. Key Findings
  • 11.2. Introduction
    • 11.2.1. Molecular Infectious Disease Testing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 11.3. Molecular Infectious Disease Testing Market - North America
    • 11.3.1. North America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.3.2. North America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.3.3. North America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.3.4. North America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.3.5. North America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.3.6. North America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.3.7. Molecular Infectious Disease Testing Market - US
      • 11.3.7.1. US: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.3.7.2. US: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.3.7.3. US: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.3.7.4. US: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.3.7.5. US: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.3.7.6. US: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.3.8. Molecular Infectious Disease Testing Market - Canada
      • 11.3.8.1. Canada: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.3.8.2. Canada: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.3.8.3. Canada: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.3.8.4. Canada: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.3.8.5. Canada: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.3.8.6. Canada: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.4. Molecular Infectious Disease Testing Market - Europe
    • 11.4.1. Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.4.2. Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.4.3. Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.4.4. Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.4.5. Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.4.6. Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.7. Molecular Infectious Disease Testing Market - UK
      • 11.4.7.1. UK: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.7.2. UK: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.7.3. UK: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.7.4. UK: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.7.5. UK: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.7.6. UK: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.8. Molecular Infectious Disease Testing Market - France
      • 11.4.8.1. France: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.8.2. France: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.8.3. France: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.8.4. France: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.8.5. France: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.8.6. France: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.9. Molecular Infectious Disease Testing Market - Germany
      • 11.4.9.1. Germany: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.9.2. Germany: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.9.3. Germany: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.9.4. Germany: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.9.5. Germany: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.9.6. Germany: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.10. Molecular Infectious Disease Testing Market - Italy
      • 11.4.10.1. Italy: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.10.2. Italy: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.10.3. Italy: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.10.4. Italy: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.10.5. Italy: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.10.6. Italy: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.11. Molecular Infectious Disease Testing Market - Spain
      • 11.4.11.1. Spain: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.11.2. Spain: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.11.3. Spain: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.11.4. Spain: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.11.5. Spain: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.11.6. Spain: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.12. Molecular Infectious Disease Testing Market - Netherlands
      • 11.4.12.1. Netherlands: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.12.2. Netherlands: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.12.3. Netherlands: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.12.4. Netherlands: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.12.5. Netherlands: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.12.6. Netherlands: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.13. Molecular Infectious Disease Testing Market - Russia
      • 11.4.13.1. Russia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.13.2. Russia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.13.3. Russia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.13.4. Russia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.13.5. Russia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.13.6. Russia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.14. Molecular Infectious Disease Testing Market - Rest of Europe
      • 11.4.14.1. Rest of Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.14.2. Rest of Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.14.3. Rest of Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.14.4. Rest of Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.14.5. Rest of Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.14.6. Rest of Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.5. Molecular Infectious Disease Testing Market - Asia Pacific
    • 11.5.1. Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.5.2. Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.5.3. Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.5.4. Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.5.5. Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.5.6. Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.7. Molecular Infectious Disease Testing Market - China
      • 11.5.7.1. China: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.7.2. China: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.7.3. China: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.7.4. China: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.7.5. China: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.7.6. China: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.8. Molecular Infectious Disease Testing Market - India
      • 11.5.8.1. India: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.8.2. India: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.8.3. India: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.8.4. India: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.8.5. India: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.8.6. India: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.9. Molecular Infectious Disease Testing Market - Malaysia
      • 11.5.9.1. Malaysia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.9.2. Malaysia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.9.3. Malaysia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.9.4. Malaysia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.9.5. Malaysia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.9.6. Malaysia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.10. Molecular Infectious Disease Testing Market - Japan
      • 11.5.10.1. Japan: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.10.2. Japan: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.10.3. Japan: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.10.4. Japan: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.10.5. Japan: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.10.6. Japan: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.11. Molecular Infectious Disease Testing Market - Indonesia
      • 11.5.11.1. Indonesia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.11.2. Indonesia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.11.3. Indonesia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.11.4. Indonesia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.11.5. Indonesia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.11.6. Indonesia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.12. Molecular Infectious Disease Testing Market - South Korea
      • 11.5.12.1. South Korea: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.12.2. South Korea: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.12.3. South Korea: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.12.4. South Korea: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.12.5. South Korea: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.12.6. South Korea: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.13. Molecular Infectious Disease Testing Market - Australia
      • 11.5.13.1. Australia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.13.2. Australia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.13.3. Australia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.13.4. Australia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.13.5. Australia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.13.6. Australia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.14. Molecular Infectious Disease Testing Market - Rest of Asia Pacific
      • 11.5.14.1. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.14.2. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.14.3. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.14.4. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.14.5. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.14.6. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.6. Molecular Infectious Disease Testing Market - Middle East & Africa
    • 11.6.1. Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.6.2. Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.6.3. Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.6.4. Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.6.5. Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.6.6. Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.6.7. Molecular Infectious Disease Testing Market - Saudi Arabia
      • 11.6.7.1. Saudi Arabia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.6.7.2. Saudi Arabia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.6.7.3. Saudi Arabia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.6.7.4. Saudi Arabia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.6.7.5. Saudi Arabia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.6.7.6. Saudi Arabia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.6.8. Molecular Infectious Disease Testing Market - UAE
      • 11.6.8.1. UAE: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.6.8.2. UAE: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.6.8.3. UAE: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.6.8.4. UAE: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.6.8.5. UAE: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.6.8.6. UAE: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.6.9. Molecular Infectious Disease Testing Market - Israel
      • 11.6.9.1. Israel: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.6.9.2. Israel: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.6.9.3. Israel: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.6.9.4. Israel: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.6.9.5. Israel: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.6.9.6. Israel: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.6.10. Molecular Infectious Disease Testing Market - South Africa
      • 11.6.10.1. South Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.6.10.2. South Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.6.10.3. South Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.6.10.4. South Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.6.10.5. South Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.6.10.6. South Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.6.11. Molecular Infectious Disease Testing Market - Rest of Middle East & Africa
      • 11.6.11.1. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.6.11.2. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.6.11.3. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.6.11.4. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.6.11.5. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.6.11.6. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.7. Molecular Infectious Disease Testing Market - Latin America
    • 11.7.1. Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.7.2. Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.7.3. Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.7.4. Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.7.5. Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.7.6. Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.7.7. Molecular Infectious Disease Testing Market - Mexico
      • 11.7.7.1. Mexico: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.7.7.2. Mexico: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.7.7.3. Mexico: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.7.7.4. Mexico: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.7.7.5. Mexico: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.7.7.6. Mexico: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.7.8. Molecular Infectious Disease Testing Market - Brazil
      • 11.7.8.1. Brazil: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.7.8.2. Brazil: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.7.8.3. Brazil: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.7.8.4. Brazil: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.7.8.5. Brazil: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.7.8.6. Brazil: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.7.9. Molecular Infectious Disease Testing Market - Argentina
      • 11.7.9.1. Argentina: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.7.9.2. Argentina: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.7.9.3. Argentina: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.7.9.4. Argentina: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.7.9.5. Argentina: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.7.9.6. Argentina: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.7.10. Molecular Infectious Disease Testing Market - Rest of Latin America
      • 11.7.10.1. Rest of Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.7.10.2. Rest of Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.7.10.3. Rest of Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.7.10.4. Rest of Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.7.10.5. Rest of Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.7.10.6. Rest of Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)

12. Competitive Landscape

  • 12.1. Expansion and Acquisition Analysis
    • 12.1.1. Expansion
    • 12.1.2. Acquisitions
  • 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

  • 13.1. Abbott
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Benchmarking
    • 13.1.4. Recent Development
  • 13.2. Agilent Technologies, Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Benchmarking
    • 13.2.4. Recent Development
  • 13.3. Becton, Dickinson and Company
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Benchmarking
    • 13.3.4. Recent Development
  • 13.4. bioMérieux SA
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Benchmarking
    • 13.4.4. Recent Development
  • 13.5. Bio-Rad Laboratories, Inc.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Benchmarking
    • 13.5.4. Recent Development
  • 13.6. Bruker Corporation
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Benchmarking
    • 13.6.4. Recent Development
  • 13.7. Danaher Corporation
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Benchmarking
    • 13.7.4. Recent Development
  • 13.8. F. Hoffmann-La Roche Ltd
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Benchmarking
    • 13.8.4. Recent Development
  • 13.9. Grifols S.A.
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Benchmarking
    • 13.9.4. Recent Development
  • 13.10. Hologic, Inc. (Gen-Probe)
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Benchmarking
    • 13.10.4. Recent Development
  • 13.11. Illumina, Inc.
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Benchmarking
    • 13.11.4. Recent Development
  • 13.12. Qiagen
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Benchmarking
    • 13.12.4. Recent Development
  • 13.13. Siemens Healthineers AG
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Benchmarking
    • 13.13.4. Recent Development
  • 13.14. Sysmex Corporation
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Benchmarking
    • 13.14.4. Recent Development
  • 13.15. Thermo Fisher Scientific
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Benchmarking
    • 13.15.4. Recent Development

List of Tables:

  • Table 1 Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 2 Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 3 Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 4 UK: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 5 UK: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 6 UK: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 7 UK: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 8 UK: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 9 UK: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 10 France: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 11 France: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 12 France: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 13 France: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 14 France: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 15 France: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 16 Germany: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 17 Germany: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Germany: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 19 Germany: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 20 Germany: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 21 Germany: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 22 Italy: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 23 Italy: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 24 Italy: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 25 Italy: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 26 Italy: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 27 Italy: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 28 Spain: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 29 Spain: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 30 Spain: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 31 Spain: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 32 Spain: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 33 Spain: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 34 Netherlands: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 35 Netherlands: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 36 Netherlands: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 37 Netherlands: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 38 Netherlands: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 39 Netherlands: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 40 Russia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 41 Russia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Russia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 43 Russia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 44 Russia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 45 Russia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 46 Rest of Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 47 Rest of Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Rest of Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 52 Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 57 Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 58 China: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 59 China: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 60 China: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 61 China: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 62 China: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 63 China: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 64 India: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 65 India: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 66 India: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 67 India: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 68 India: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 69 India: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 70 Malaysia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 71 Malaysia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 72 Malaysia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 73 Malaysia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 74 Malaysia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 75 Malaysia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 76 Japan: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 77 Japan: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 78 Japan: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 79 Japan: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 80 Japan: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 81 Japan: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 82 Indonesia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 83 Indonesia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 84 Indonesia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 85 Indonesia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 86 Indonesia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 87 Indonesia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 88 South Korea: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 89 South Korea: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 90 South Korea: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 91 South Korea: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 92 South Korea: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 93 South Korea: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 94 Australia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 95 Australia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 96 Australia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 97 Australia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 98 Australia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 99 Australia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 100 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 101 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 102 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 103 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 104 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 105 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 106 Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 107 Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 108 Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 109 Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 110 Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 112 Saudi Arabia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 113 Saudi Arabia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 114 Saudi Arabia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 115 Saudi Arabia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 118 UAE: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 119 UAE: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 120 UAE: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 121 UAE: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 122 UAE: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 123 UAE: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 124 Israel: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 125 Israel: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 126 Israel: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 127 Israel: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 128 Israel: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 129 Israel: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 130 South Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 131 South Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 132 South Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 133 South Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 134 South Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 135 South Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 141 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 142 Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 143 Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 144 Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 145 Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 146 Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 147 Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 148 Mexico: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 149 Mexico: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 150 Mexico: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 151 Mexico: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 152 Mexico: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 153 Mexico: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 154 Brazil: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 155 Brazil: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 156 Brazil: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 157 Brazil: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 158 Brazil: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 159 Brazil: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 160 Argentina: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 161 Argentina: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 162 Argentina: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 163 Argentina: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 164 Argentina: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 165 Argentina: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 166 Rest of Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 167 Rest of Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 168 Rest of Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 169 Rest of Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 170 Rest of Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 171 Rest of Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Molecular Infectious Disease Testing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product & Service
  • Figure 7. Global Molecular Infectious Disease Testing Market, by Product & Service, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Molecular Infectious Disease Testing Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Test Type
  • Figure 11. Global Molecular Infectious Disease Testing Market, by Test Type, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Disease
  • Figure 13. Global Molecular Infectious Disease Testing Market, by Disease, 2024 & 2034 (USD Billion)
  • Figure 14. Market by Technology
  • Figure 15. Global Molecular Infectious Disease Testing Market, by Technology, 2024 & 2034 (USD Billion)
  • Figure 16. Market by End User
  • Figure 17. Global Molecular Infectious Disease Testing Market, by End User, 2024 & 2034 (USD Billion)